Therapeutic potential of TLR8 agonist GS‐9688 (selgantolimod) in chronic hepatitis B: re‐modelling of antiviral and regulatory mediators

Title
Therapeutic potential of TLR8 agonist GS‐9688 (selgantolimod) in chronic hepatitis B: re‐modelling of antiviral and regulatory mediators
Authors
Keywords
-
Journal
HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-26
DOI
10.1002/hep.31695

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now